{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:43:25Z","timestamp":1790725405292,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012905","name":"Department of Science and Technology of Shandong Province","doi-asserted-by":"publisher","award":["2016GSF201192"],"award-info":[{"award-number":["2016GSF201192"]}],"id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014417","name":"Fundamental Research Fund of Shandong University","doi-asserted-by":"publisher","award":["2017JC035"],"award-info":[{"award-number":["2017JC035"]}],"id":[{"id":"10.13039\/100014417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.intimp.2019.106012","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:57:42Z","timestamp":1576663062000},"page":"106012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages"],"prefix":"10.1016","volume":"78","author":[{"given":"Weiqiang","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA. Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.intimp.2019.106012_b0010","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","article-title":"A single-cell atlas of the tumor and immune ecosystem of human breast cancer","volume":"177","author":"Wagner","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-016-9649-6","article-title":"The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer","volume":"35","author":"Hsu","year":"2016","journal-title":"Cancer Metastasis Rev."},{"issue":"7749","key":"10.1016\/j.intimp.2019.106012_b0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","article-title":"Glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","article-title":"Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting Integrin\/FAK and EGFR Signaling","volume":"35","author":"Shen","year":"2019","journal-title":"Cancer Cell"},{"issue":"7751","key":"10.1016\/j.intimp.2019.106012_b0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism","volume":"568","author":"Lee","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2019.106012_b0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2019.106012_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2018.08.025","article-title":"Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-\u03b1 and MMP-9","volume":"437","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.intimp.2019.106012_b0050","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","article-title":"Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression which can be inhibited by CCR5 inhibition Therapy","volume":"25","author":"Hu","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2019.106012_b0055","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-17-2158","article-title":"Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and Cancer Mesenchymal Cells Through a Complex Cytokine Network","volume":"79","author":"Valeta-Magara","year":"2019","journal-title":"Cancer Res."},{"issue":"7355","key":"10.1016\/j.intimp.2019.106012_b0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ccell.2019.03.010","article-title":"Deciphering macrophage and monocyte code to stratify human breast cancer patients","volume":"35","author":"Bronte","year":"2019","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","article-title":"Extracellular vesicle-packaged HIF-1\u03b1-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells","volume":"21","author":"Chen","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2019.106012_b0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106012_b0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jb\/mvy050","article-title":"CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid","volume":"164","author":"Asano","year":"2018","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2019.106012_b0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.20101688","article-title":"Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche","volume":"208","author":"Chow","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2019.106012_b0095","doi-asserted-by":"crossref","unstructured":"O.A. Perez, S.T. Yeung, P. Vera-Licona, P.A. Romagnoli, T. Samji, B.B. Ural, L. Maher, M. Tanaka, K.M. Khanna, CD169+ macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen. Sci. Immunol. 2 (16) (2017) pii: eaah5520.","DOI":"10.1126\/sciimmunol.aah5520"},{"issue":"8","key":"10.1016\/j.intimp.2019.106012_b0100","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI31990","article-title":"Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens","volume":"117","author":"Miyake","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.3057","article-title":"CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress","volume":"19","author":"Chow","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.106012_b0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellimm.2017.09.006","article-title":"Targeting macrophages for cancer therapy disrupts bone homeostasis and impairs bone marrow erythropoiesis in mice bearing Lewis lung carcinoma tumors","volume":"331","author":"Jing","year":"2018","journal-title":"Cell Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2019.106012_b0115","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/2326-6066.CIR-14-0180","article-title":"Prognostic significance of CD169+ Lymph Node Sinus macrophages in patients with Malignant Melanoma","volume":"3","author":"Saito","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2019.106012_b0120","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1177690","article-title":"CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.intimp.2019.106012_b0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/cas.12929","article-title":"Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma","volume":"107","author":"Ohnishi","year":"2016","journal-title":"Cancer Sci."},{"issue":"15","key":"10.1016\/j.intimp.2019.106012_b0130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/pros.23407","article-title":"Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients","volume":"77","author":"Str\u00f6mvall","year":"2017","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.intimp.2019.106012_b0135","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/cas.13565","article-title":"CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis","volume":"109","author":"Asano","year":"2018","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.intimp.2019.106012_b0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/pin.12736","article-title":"High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer","volume":"68","author":"Takeya","year":"2018","journal-title":"Pathol. Int."},{"issue":"11","key":"10.1016\/j.intimp.2019.106012_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166680","article-title":"The clinical significance of CD169-positive lymph node macrophage in patients with breast cancer","volume":"11","author":"Shiota","year":"2016","journal-title":"PLoS One"},{"issue":"6282","key":"10.1016\/j.intimp.2019.106012_b0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","article-title":"CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens","volume":"34","author":"Asano","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/0284186X.2017.1400180","article-title":"Triple negative breast cancer - prognostic role of immune-related factors: a systematic review","volume":"57","author":"Stovgaard","year":"2018","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2019.106012_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121921","article-title":"Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.intimp.2019.106012_b0175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/90795","article-title":"Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice","volume":"19","author":"Saito","year":"2001","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2019.106012_b0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nmeth762","article-title":"A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration","volume":"2","author":"Buch","year":"2005","journal-title":"Nat. Methods."},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2958.2003.03550.x","article-title":"Transgenic mice expressing the diphtheria toxin receptor are sensitive to the toxin","volume":"49","author":"Cha","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0190","doi-asserted-by":"crossref","first-page":"1599680","DOI":"10.1080\/20013078.2019.1599680","article-title":"Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b","volume":"8","author":"Vu","year":"2019","journal-title":"J. Extracell Vesicles"},{"issue":"7","key":"10.1016\/j.intimp.2019.106012_b0195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2019.106012_b0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.106012_b0205","doi-asserted-by":"crossref","unstructured":"D. Merino, J.R. Whittle, F. Vaillant, A. Serrano, J.N. Gong, G. Giner, A.L. Maragno, M. Chanrion, E. Schneider, B. Pal, X. Li, G. Dewson, J. Gr\u00e4sel, K. Liu, N. Lalaoui, D. Segal, M.J. Herold, D.C.S. Huang, G.K. Smyth, O. Geneste, G. Lessene, J.E. Visvader, G.J. Lindeman, Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer. Sci. Transl. Med. 9 (401) (2017) pii: eaam7049.","DOI":"10.1126\/scitranslmed.aam7049"},{"key":"10.1016\/j.intimp.2019.106012_b0210","doi-asserted-by":"crossref","unstructured":"G.R. Anderson, S.E. Wardell, M. Cakir, L. Crawford, J.C. Leeds, D.P. Nussbaum, P.S. Shankar, R.S. Soderquist, E.M. Stein, J.P. Tingley, P.S. Winter, E.K. Zieser-Misenheimer, H.M. Alley, A. Yllanes, V. Haney, K.L. Blackwell, S.J. McCall, D.P. McDonnell, K.C. Wood, PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. Sci. Transl. Med. 8 (369) (2016) 369ra175.","DOI":"10.1126\/scitranslmed.aae0348"},{"issue":"3","key":"10.1016\/j.intimp.2019.106012_b0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1074\/jbc.RA118.004712","article-title":"Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells","volume":"294","author":"Gayle","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.106012_b0220","doi-asserted-by":"crossref","unstructured":"X. Li, T. Gruosso, D. Zuo, A. Omeroglu, S. Meterissian, M.C. Guiot, A. Salazar, M. Park, Levine H. Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer. Proc. Natl. Acad. Sci. U. S. A. 116 (9) (2019) 3678\u20133687.","DOI":"10.1073\/pnas.1817652116"},{"key":"10.1016\/j.intimp.2019.106012_b0225","doi-asserted-by":"crossref","unstructured":"L.F. Gemta, P.J. Siska, M.E. Nelson, X. Gao, X. Liu, J.W. Locasale, H. Yagita, C.L. Slingluff Jr., K.L. Hoehn, J.C. Rathmell, T.N.J. Bullock, Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells. Sci. Immunol. 4 (31) (2019) pii: eaap9520.","DOI":"10.1126\/sciimmunol.aap9520"},{"issue":"3","key":"10.1016\/j.intimp.2019.106012_b0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.106012_b0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/CMAR.S157512","article-title":"A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.intimp.2019.106012_b0240","doi-asserted-by":"crossref","unstructured":"T.L. Arenzana, S. Lianoglou, A. Seki, C. Eidenschenk, T. Cheung, D. Seshasayee, T. Hagenbeek, A. Sambandam, R. Noubade, I. Peng, J. Lesch, J. DeVoss, X. Wu, W.P. Lee, P. Caplazi, J. Webster, J. Liu, V.C. Pham, D. Arnott, J.R. Lill, Z. Modrusan, A. Dey, S. Rutz, Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes. Sci. Immunol. 3 (22) (2018) pii: eaal1953.","DOI":"10.1126\/sciimmunol.aal1953"},{"key":"10.1016\/j.intimp.2019.106012_b0245","doi-asserted-by":"crossref","unstructured":"R. Hasadia, O. Kazarin, O. Sofer, K. Shulman, A. Troitsa, R. Alfici, I. Ashkenazi, Splenectomy for breast carcinoma diffusely metastatic to the spleen presenting as severe transfusion-dependent anaemia and thrombocytopaenia. BMJ Case Rep. 11 (1) (2018) pii: e223453.","DOI":"10.1136\/bcr-2017-223453"},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13256-016-1180-4","article-title":"Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report","volume":"11","author":"Elm'hadi","year":"2017","journal-title":"J. Med. Case Rep."},{"issue":"6","key":"10.1016\/j.intimp.2019.106012_b0255","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1464-410X.1991.tb15234.x","article-title":"Spontaneous rupture of splenomegaly due to disseminated bone metastases from prostatic carcinoma","volume":"67","author":"Van Poppel","year":"1991","journal-title":"Br. J. Urol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106012_b0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jcp.56.9.709","article-title":"Splenic rupture as a consequence of dual malignant pathology: a case report","volume":"56","author":"Hoar","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"20","key":"10.1016\/j.intimp.2019.106012_b0265","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.vaccine.2013.03.028","article-title":"Expression of membrane anchored cytokines and B7\u20131 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model","volume":"31","author":"Bozeman","year":"2013","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.intimp.2019.106012_b0270","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.intimp.2009.03.015","article-title":"Gemcitabine directly inhibits myeloid derived suppressor cells in BALB\/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice","volume":"9","author":"Le","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0275","doi-asserted-by":"crossref","first-page":"667.e1","DOI":"10.1016\/j.ajem.2016.11.010","article-title":"Splenic rupture after emesis: a rare finding of generalized abdominal pain","volume":"35","author":"Sullivan","year":"2017","journal-title":"Am. J. Emerg. Med."},{"issue":"4 Suppl","key":"10.1016\/j.intimp.2019.106012_b0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jviscsurg.2016.04.005","article-title":"Management of splenic and pancreatic trauma","volume":"153","author":"Girard","year":"2016","journal-title":"J. Visc. Surg."},{"issue":"8","key":"10.1016\/j.intimp.2019.106012_b0285","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106012_b0290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3324\/haematol.2014.112813","article-title":"The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study","volume":"100","author":"Macci\u00f2","year":"2015","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.intimp.2019.106012_b0295","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bjc.2012.42","article-title":"Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer","volume":"106","author":"Aapro","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2019.106012_b0300","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2019.106012_b0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of triple-negative breast cancer cells by targeting Glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2019.106012_b0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.intimp.2018.12.018","article-title":"Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1\/PD-L1 inhibitors) treatments for urothelial carcinoma patients: a meta-analysis","volume":"67","author":"Rui","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106012_b0315","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2019.106012_b0320","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1016\/j.clbc.2018.05.006","article-title":"JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple-negative breast cancer","volume":"18","author":"Chen","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.intimp.2019.106012_b0325","doi-asserted-by":"crossref","unstructured":"A. Prestipino, A.J. Emhardt, K. Aumann, D. O'Sullivan, S.P. Gorantla, S. Duquesne, W. Melchinger, L. Braun, S. Vuckovic, M. Boerries, H. Busch, S. Halbach, S. Pennisi, T. Poggio, P. Apostolova, P. Veratti, M. Hettich, G. Niedermann, M. Bartholom\u00e4, K. Shoumariyeh, J.S. Jutzi, J. Wehrle, C. Dierks, H. Becker, A. Schmitt-Graeff, M. Follo, D. Pfeifer, J. Rohr, S. Fuchs, S. Ehl, F.A. Hartl, S. Minguet, C. Miething, F.H. Heidel, N. Kr\u00f6ger, I. Triviai, T. Brummer, J. Finke, A.L. Illert, E. Ruggiero, C. Bonini, J. Duyster, H.L. Pahl, S.W. Lane, G.R. Hill, B.R. Blazar, N. von Bubnoff, E.L. Pearce, R. Zeiser, Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Sci. Transl. Med. 10 (429) (2018) pii: eaam7729.","DOI":"10.1126\/scitranslmed.aam7729"},{"issue":"4","key":"10.1016\/j.intimp.2019.106012_b0330","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/1535-7163.MCT-17-0667","article-title":"JAK2 Inhibitor SAR302503 Abrogates PD-L1 expression and targets therapy-resistant non-small cell lung cancers","volume":"17","author":"Pitroda","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"18","key":"10.1016\/j.intimp.2019.106012_b0335","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1158\/1078-0432.CCR-18-0267","article-title":"MET-Oncogenic and JAK2-inactivating alterations are independent factors that affect regulation of PD-L1 expression in lung cancer","volume":"24","author":"Saigi","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2019.106012_b0340","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1074-7613(00)80504-X","article-title":"Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice","volume":"5","author":"Liu","year":"1996","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2019.106012_b0345","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1073\/pnas.1424927112","article-title":"Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils","volume":"112","author":"Casbon","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.intimp.2019.106012_b0350","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V86.10.3698.bloodjournal86103698","article-title":"Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK","volume":"86","author":"Nicholson","year":"1995","journal-title":"Blood"},{"issue":"50","key":"10.1016\/j.intimp.2019.106012_b0355","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes","volume":"107","author":"Kowanetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.intimp.2019.106012_b0360","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","article-title":"Tumor-infiltrating and peripheral blood T-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma","volume":"23","author":"Giraldo","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6449","key":"10.1016\/j.intimp.2019.106012_b0365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aav8692","article-title":"Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor","volume":"365","author":"Ma","year":"2019","journal-title":"Science"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:15Z","timestamp":1761585195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919315838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":73,"alternative-id":["S1567576919315838"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106012","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106012"}}